In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing ...
Global pharmaceutical production surged in 2025 due to tariff-driven front-loading but is expected to slow as trade ...
Blood transfusions are essential for patients with cancer, sickle cell disease, and traumatic injuries, but blood supply ...
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...
The United States’ official exit from the World Health Organization (WHO) is set to be finalized today, Thursday January 22, ...
Pharmaceutical Executive: What was Daiichi Sankyo's strategy for preparing for the JP Morgan Healthcare Conference? Ken ...
Janux Therapeutics has partnered with Bristol Myers Squibb in a global licensing and collaboration deal to advance a ...
Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...
In today’s Pharmaceutical Executive Daily, a new study reignites debate over a potential link between Tylenol use and autism risk, TopGum signs a $12 million letter of intent to acquire US ...
TopGum Industries signed a binding letter of intent to acquire U.S.-based operations manufacturing pharmaceutical products ...
AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...
In today’s Pharmaceutical Executive Daily, GSK moves to strengthen its immunology pipeline with a $2 billion acquisition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results